April 9, 2021Letter Agreement • April 29th, 2021 • Evelo Biosciences, Inc. • Pharmaceutical preparations
Reference is made to my letter dated as of September 16, 2019 addressed to you concerning your compensation for serving as the Chair of the Board of Directors of Evelo Biosciences, Inc. (as previously amended, the “Letter Agreement”). This letter memorializes our recent discussion concerning an amendment to your compensation, and will become effective upon your signature below (the “Amendment”).
Evelo Biosciences, Inc. Amendment No. 2 to Consulting AgreementConsulting Agreement • April 29th, 2021 • Evelo Biosciences, Inc. • Pharmaceutical preparations
This Amendment to that certain Consulting Agreement dated as of September 16, 2019 (as previously amended, the “Agreement”) is entered into by and between Evelo Biosciences, Inc., a Delaware corporation with a place of business located at 620 Memorial Drive, Cambridge, Massachusetts 02139, USA (the “Company”), and David Epstein, an individual residing at [***] (the “Consultant”).
